COVID-19 and Type 2 diabetes Regional experts shed light latest scientific updates and
COVID-19 and Type 2 diabetes: Regional experts shed light on the latest scientific updates and clinical practices in disease management for patient education
Search
PCI with stenting animation
A short animation explaining what Percutaneous Coronary Intervention (PCI) with stenting is, why it is used in AF patients and the unmet need in current treatment strategies
Biotherapeutics Discovery
We are applying our deep understanding of disease biology to design a diverse range of novel modalities that are the foundation for life-changing biotherapeutics for patients.
DHA and Boehringer Set Guinness World Records™ Title
Boehringer Ingelheim, in collaboration with the DHA created the world’s “Largest light mosaic (image)” to illuminate the connections between CRM diseases and raise awareness about the importance of early diagnosis and holistic
Patient documentary - From diagnosis to everyday living
Patient documentary - From diagnosis to everyday living
COVID-19 Q&A for people with diabetes
COVID-19 Q&A for people with diabetes
COVID-19 Q&A for people with chronic respiratory conditions
COVID-19 Q&A for people with chronic respiratory conditions
Boehringer Ingelheim unites dermatologists to discuss the management of Generalized Pustular Psoriasis (GPP)
The ‘GPP Summit, discussed latest research and advances in the management of GPP to help improve patient outcomes across Saudi Arabia, and the United Arab Emirates.
Making Every Second Count
The Angels initiative honours emergency response teams making a difference for stroke patients
Boehringer Ingelheim and Alpha Pharma Collaborate to localize the production of one of its Type 2 Diabetes Medicines in Saudi Arabia
Boehringer Ingelheim is driving localization capacities with robust partnerships in alignment with Vision 2030
GPP Interview with Professor Barker
An interview with Prof. Barker about generalized pustular psoriasis, its burden on patients and how patient outcomes can be improved
Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies.
‘Angels’ Initiative is Launched to Deliver Medical Education on Stroke Management at University
‘Angels’ Initiative is Launched to Deliver Medical Education on Stroke Management at University Hospitals
Our-position
Potential access to selected medications for appropriate patients with serious, life-threatening diseases unable to participate in a clinical trial
Giving Life a Chance
The Angels initiative honours stroke units and the everyday heroes making a difference for stroke patients
World Recycling Day: Closing the Loop
Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential
Boehringer launches the Treatment for Three Interstitial Lung Diseases in Qatar
• This is the first time that an approved antifibrotic medication will be available for ILD patients residing in Qatar
Oncology and Cancer Immunology Research
Find out more about our research and development in oncology and cancer immunology.
Elevating Cardio-Renal-Metabolic Care: Boehringer Ingelheim Imparts Latest Insights to 400 Regional Experts
Boehringer Ingelheim hosted the ‘CRM Summit’ to facilitate exchanges and discussions on the latest advances in the management of cardiovascular, renal, and metabolic diseases to help improve patient outcomes across India, the Middle East and Africa
Mechanistic Modeling in Biotherapeutic Drug Development
Mechanistic modeling is revolutionizing biotherapeutic drug development with the goal of getting new medicines to patients faster, more reliably and more cost-effectively.
Boehringer Ingelheim Convenes Educational Meetings to Empower Over 300 Regional Experts with Latest Heart Failure Advances
• Boehringer Ingelheim hosted ‘Heart Talks’and ‘MEDEX’ to discuss latest updates in heart failure management and help improve patient outcomes across India, the Middle East and Africa
Combination Therapy
We are designing smart combinations of immuno-oncology and cancer cell directed therapies to maximise the benefit to our patients.
COPD Patient brochure
EURORDIS Award
EURORDIS has selected Boehringer Ingelheim for the first time as recipient of the prestigious Black Pearl Award 2020
Translational Medicine in Immunology
Find out how translational medicine is helping bring transformational therapies to patients